Aligos Therapeutics Inc (ALGS)

02:07 AM

Aligos Therapeutics provides update on ALG-000184 for chronic hepatitis B - European AIDS Treatment Group

02:07 AM

10:14 AM

Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus - Zacks Investment Research

10:14 AM

08:18 AM

Custom watchlist performance reports with Aligos Therapeutics Inc.Market Weekly Review & Weekly High Conviction Ideas - Newser

08:18 AM

07:24 AM

Aligos Therapeutics Inc. stock momentum explainedWeekly Stock Recap & Free Community Consensus Stock Picks - Newser

07:24 AM

06:40 AM

Will Aligos Therapeutics Inc. continue its uptrendMarket Growth Summary & Capital Protection Trading Alerts - Newser

06:40 AM

05:51 AM

Aligos commences dosing in Phase II trial for chronic hepatitis B treatment - Yahoo Finance

05:51 AM

04:24 AM

How Efficient Is Aligos Therapeutics Inc. at Controlling Operating CostsJuly 2025 Macro Moves & High Accuracy Investment Signals - Newser

04:24 AM

04:01 AM

Can Aligos Therapeutics Inc. rally from current levelsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - Newser

04:01 AM

03:12 AM

Does Aligos Therapeutics Inc. show high probability of rebound2025 Price Momentum & Consistent Growth Stock Picks - Newser

03:12 AM

01:34 AM

Will Aligos Therapeutics Inc. stock recover after recent drop2025 Key Highlights & Risk Controlled Stock Alerts - Newser

01:34 AM

01:32 AM

Why Aligos Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 EndofMonth & Verified Technical Signals - Newser

01:32 AM

Aug 13, 2025

What indicators show strength in Aligos Therapeutics Inc.Volume Spike & Short-Term Trading Alerts - Newser

Aug 13, 2025

Aug 13, 2025

Best data tools to analyze Aligos Therapeutics Inc. stock2025 Year in Review & Momentum Based Trading Ideas - Newser

Aug 13, 2025

Aug 13, 2025

Moving Average Trends for Aligos Therapeutics Inc. Stock: What They IndicateBreakout Watch & Low Risk High Win Rate Picks - Newser

Aug 13, 2025

Aug 13, 2025

How to monitor Aligos Therapeutics Inc. with trend dashboardsJuly 2025 Action & Pattern Based Trade Signal System - Newser

Aug 13, 2025

Aug 13, 2025

Aligos begins dosing in phase 2 HBV drug study By Investing.com - Investing.com Australia

Aug 13, 2025

Aug 13, 2025

Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection - The Manila Times

Aug 13, 2025

Aug 13, 2025

Aligos Therapeutics shares fall 2.35% premarket after dosing initiated in Phase 2 B-SUPREME study. - AInvest

Aug 13, 2025

Aug 13, 2025

Aligos begins dosing in phase 2 HBV drug study - Investing.com

Aug 13, 2025

Aug 13, 2025

Aligos Therapeutics Initiates Dosing in Phase 2 B-SUPREME Study for Chronic Hepatitis B Virus Infection - Quiver Quantitative

Aug 13, 2025

Aug 13, 2025

Aligos Begins Major Phase 2 Study Testing Potential Best-in-Class Hepatitis B Drug - Stock Titan

Aug 13, 2025

Aug 13, 2025

Aligos Therapeutics Inc. stock outlook for YEARJuly 2025 PreEarnings & Long-Term Capital Growth Strategies - Newser

Aug 13, 2025

Aug 13, 2025

Volatility clustering patterns for Aligos Therapeutics Inc. [July 2025 EndofMonth]Free Weekly High Return Stock Opportunities - Newser

Aug 13, 2025

Aug 12, 2025

News impact scoring models applied to Aligos Therapeutics Inc.Near-Term Market Opportunity Forecast Sheet - Newser

Aug 12, 2025

Aug 12, 2025

Smart tools for monitoring Aligos Therapeutics Inc.’s price actionShort Term Momentum Based Trading Strategy - Newser

Aug 12, 2025

Aug 12, 2025

Is it too late to sell Aligos Therapeutics Inc.Weekly Market Summary & Stock Market Timing Techniques - Newser

Aug 12, 2025

Aug 12, 2025

Will Aligos Therapeutics Inc. price bounce be sustainableFree Low Capital High Return Stock Plans - Newser

Aug 12, 2025

Aug 12, 2025

Can ALGS sustain its earnings growth beyond 2024? - AInvest

Aug 12, 2025

Aug 12, 2025

What's behind ALGS' volatile quarterly earnings? - AInvest

Aug 12, 2025

Aug 11, 2025

Ranking Aligos Therapeutics Inc. among high performing stocks via toolsFree AI-Powered Trade Planning with Indicators - Newser

Aug 11, 2025

Aug 11, 2025

Using Bollinger Bands to evaluate Aligos Therapeutics Inc.Weekly High Conviction Trade Setup Analysis - Newser

Aug 11, 2025

Aug 09, 2025

Aligos Therapeutics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 09, 2025

Aug 09, 2025

What explains ALGS' consistent earnings surprises? - AInvest

Aug 09, 2025

Aug 09, 2025

Will Aligos Therapeutics Inc. stock go up soonExpert-Backed High Yield Stock Watchlist - Newser

Aug 09, 2025

Aug 09, 2025

Is Aligos Therapeutics Inc. showing signs of accumulationConsistent Gain Plan with AI Support - Newser

Aug 09, 2025

Aug 09, 2025

Volatility clustering patterns for Aligos Therapeutics Inc.Free Proven Entry Plan With Low Risk Trade - Newser

Aug 09, 2025

Aug 08, 2025

Aligos Therapeutics Reports Q2 EPS of $1.53, Misses Consensus - AInvest

Aug 08, 2025